Portulaca oleracea Extract Ameliorates Testosterone Propionate-Induced Benign Prostatic Hyperplasia in Male Sprague-Dawley Rats
- PMID: 39739367
- PMCID: PMC11687364
- DOI: 10.1002/vms3.70184
Portulaca oleracea Extract Ameliorates Testosterone Propionate-Induced Benign Prostatic Hyperplasia in Male Sprague-Dawley Rats
Abstract
Benign prostatic hyperplasia (BPH) is a distressing health problem that can cause serious complications in aging men. Androgens are implicated in the causation of BPH. Portulaca oleracea (PO) is a natural product with diverse pharmacological effects. The objective of this study was to investigate the effect of PO in a rat model of testosterone propionate (TP)-induced BPH and explore the underlying mechanisms. Thirty-five Sprague-Dawley (SD) rats were divided into the following equal groups (n = 7): normal control (NC) group, TP (3 mg/kg) group, finasteride (10 mg/kg) group, 25 and 50 mg/kg PO groups. At the end of the experiment, the body weights (BWs) of the rats were measured before they were euthanized to the establishment obtain serum and prostate weight (PW). TP-induced levels of androgen-related proteins in the prostate were also investigated. In the TP group, prostate size, BW, serum DHT level, prostate epithelial cell thickness and androgen-related protein level were higher than those in the NC group (p < 0.001). PO reversed TP-induced BPH in a dose-dependent manner (p < 0.01) and its effect was similar to that of finasteride. A similar effect of PO on the androgen-related protein level was also observed. We successfully established a TP-induced BPH rat model. This is the first study to demonstrate that inhibition of androgen-related proteins using PO can alleviate BPH.
Keywords: Portulaca oleracea; androgen‐related proteins; benign prostatic hyperplasia; testosterone propionate.
© 2024 The Author(s). Veterinary Medicine and Science published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures






Similar articles
-
Protective Effects of Niclosamide Ethanolamine Against Testosterone-Induced Benign Prostatic Hyperplasia in Rats.Drug Res (Stuttg). 2025 Jul;75(6):225-234. doi: 10.1055/a-2576-4153. Epub 2025 Apr 28. Drug Res (Stuttg). 2025. PMID: 40294597
-
Doxazosin Attenuates Development of Testosterone Propionate-induced Prostate Growth by regulating TGF-β/Smad Signaling Pathway, Prostate-specific Antigen Expression and Reversing Epithelial-mesenchymal Transition in Mice and Stroma Cells.Curr Mol Pharmacol. 2024;17:e18761429315125. doi: 10.2174/0118761429315125240919033502. Curr Mol Pharmacol. 2024. PMID: 39773046
-
The Combination of Curcumae Radix and Syzygium Aromaticum Extracts Mitigates Benign Prostatic Hyperplasia through Anti-Proliferative and Anti-Inflammatory Effects.World J Mens Health. 2025 Jul;43(3):603-615. doi: 10.5534/wjmh.240071. Epub 2024 Oct 25. World J Mens Health. 2025. PMID: 39478652 Free PMC article.
-
Immune Cell Proinflammatory Microenvironment and Androgen-Related Metabolic Regulation During Benign Prostatic Hyperplasia in Aging.Front Immunol. 2022 Mar 21;13:842008. doi: 10.3389/fimmu.2022.842008. eCollection 2022. Front Immunol. 2022. PMID: 35386711 Free PMC article.
-
Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses.Cochrane Database Syst Rev. 2023 Sep 12;9(9):CD015226. doi: 10.1002/14651858.CD015226.pub2. Cochrane Database Syst Rev. 2023. PMID: 37696529 Free PMC article.
References
-
- Abdullah, M. S. , and Kusumaningtyas R. D.. 2020. “The Extraction of Purslane (Portulaca oleracea L.) Using Alcohol Solvents 48% and Its Utilization as a Source of Encapsulated Omega‐3 Oil.” In AIP Conference Proceedings. Melville, NY: AIP Publishing.
-
- Alawamlh, O. A. H. , Goueli R., and Lee R. K.. 2018. “Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia, and Urinary Retention.” Medical Clinics of North America 102: 301–311. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical